Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00284180
Status:
COMPLETED
Last Update Posted:
2013-08-09
First Post:
2006-01-27
Brief Title:
Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 HER2neu Over-Expressing Metastatic Breast Cancer
Sponsor:
Organization:
SCRI Development Innovations LLC